PARP14 and prostate neoplasm: Thus, further studies need to be carried out in order to determine whether simultaneous ectopic co-overexpression of ARTD9 together with wild type or enzymatic mutant forms of DTX3L and/or ARTD8 in xenograft prostate tumors confer docetaxel resistance and/or enhance metastasis in vivo.